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An important determinant of plasma membrane expression of intrinsic membrane proteins is N-linked glycosylation, which promotes proper folding, stability, and oligomeric assembly in the endoplasmic reticulum (ER) and facilitates transport and targeting to the plasma membrane (14, 15) . HCN1 and HCN2 are extensively N-glycosylated in mouse brain (31, 39, 58) and contain only one Asn-X-Ser/Thr consensus sequon for N-glycosylation in the S5 linker, close to the channel pore (Fig. 1, A and B) . Mutation of the Asn to Gln in the mouse (m)HCN2 isoform (mHCN2-N380Q) appears to abolish functional expression in HEK-293 cells, unique in the voltage-gated potassium channel (Kv) superfamily (31) . This abrogation of mHCN2 function in the absence of N-glycosylation may be due to impaired cell surface expression, as suggested by confocal imaging experiments that showed apparent low levels of green fluorescent protein (GFP)-tagged channels at the cell surface following treatment with the N-glycosylation inhibitor tunicamycin (31) . However, there has been no direct or quantitative measurement of mHCN2 cell surface protein to ascertain if and to what extent it is influenced by N-glycosylation. Additionally, whether mHCN1 depends on N-glycosylation to the same extent as mHCN2 is not known.
In this study, we were surprised to find that N-glycosylation is not required for mHCN2 function but that it is nevertheless tightly coupled to mHCN2 cell surface expression. mHCN1 channels are much less dependent on N-glycosylation for cell surface expression, suggesting that mHCN1 and mHCN2 genes followed diverse molecular trajectories after duplication from a common ancestor. We also found both channels in embryonic cardiac tissue, predominantly in a fully N-glycosylated state as they are in the brain.
MATERIALS AND METHODS
Mutagenesis. Asn to Gln mutations were engineered at position 327 in mHCN1 via Quickchange (Strategene) and at position 380 in mHCN2 via overlapping PCR. All mutations to Ala were made with Quickchange. For oocyte recordings, wild-type mHCN2 and mHCN2-N380Q were subcloned into the pBluescript SKϩ vector with HindIII and XbaI. Hemagglutinin (HA)-tagged constructs were generated as previously described (53) . All mutations were verified by sequencing.
Western blotting. Chinese hamster ovary (CHO) cells (American Type Culture Collection) were maintained at a subconfluent density in F-12 medium supplemented with 10% FBS. Transient transfection with FuGENE was performed according to manufacturer protocols (Roche). Twenty-four hours after transfection, cells were washed with phosphate-buffered saline (PBS) and lysed for 30 min in RIPA buffer containing (in mM) 50 Tris (pH 8.0), 150 NaCl, 1 EDTA, 1 PMSF, 2 Na 3VO4, and 2 NaF, with 1% NP-40 and 10 g/ml each of aprotinin, pepstatin, and leupeptin. Protein concentrations were determined by Bradford assay (Bio-Rad). All peptide N-glycosidase F (PNGaseF) assays were performed by incubating extracts with PNGaseF (New England Biolabs) in the presence of denaturing buffer and NP-40 for 2 h at 37°C. Proteins were resolved with SDS-PAGE and transferred to polyvinylidene difluoride (PVDF) membranes. Blots were probed with antisera to HCN1 (1:200, NeuroMab), HCN2 (1:400, Alomone), c-myc (1:500, Invitrogen), or actin (1:3,000, Invitrogen), followed by horseradish peroxidase (HRP)-conjugated secondary antibody (1:2,000, Santa Cruz), and visualized with enhanced chemiluminescence (ECL; Amersham). Scanned blots were cropped and adjusted for optimum brightness and contrast with Adobe Photoshop CS3.
For experiments using rat heart lysates, freshly dissected hearts from embryonic day (E)18 rats were dissected in Tyrode solution containing (in mM) 140 NaCl, 5.4 KCl, 1.8 CaCl 2, 1.0 MgCl2, 5 HEPES, and 5.5 glucose (pH 7.4) and homogenized in RIPA buffer. For experiments using oocyte lysates, mature decollagenated oocytes were injected with 25 ng of the indicated RNAs and maintained in OR3 medium at 18°C. Forty-eight hours after injection, 40 -50 oocytes for each condition were homogenized on ice in HEDP buffer (100 mM HEPES, 1 mM EDTA, pH 7.6) with protease inhibitors (10 g/ml each of aprotinin, pepstatin, and leupeptin and 1 Roche protease inhibitor tablet per 10 ml) and centrifuged twice at 6,000 rpm for 2 min at 4°C. Supernatants were then overlaid on a 15% sucrose-HEDP cushion and ultracentrifuged at 50,000 rpm for 90 min at 4°C to isolate membrane fractions. Pellets were resuspended in HEDP buffer, and protein concentrations were determined by Bradford assay. All experimental procedures were in accordance with guidelines from the Canadian Council for Animal Care and were approved by the University of British Columbia Committee on Animal Care.
Immunocytochemistry and microscopy. HCN2 constructs containing an HA epitope inserted between the third and fourth transmembrane segments were used to identify relative cell surface expression. Two to three days after transfection, cells on coverslips were washed with PBS and fixed in 2% paraformaldehyde in PBS for 5 min. Thereafter, they were washed with PBS, either permeabilized with 0.2% Triton X-100 or left unpermeabilized, and blocked with 10% normal goat serum (NGS). After one wash with PBS containing 1% NGS, cells were incubated with a mouse monoclonal antibody specific to the HA epitope (1:500, Sigma) for 1 h at room temperature (RT). Cells were washed with PBS-1% NGS and then incubated with a goat anti-mouse secondary antibody tagged with Alexa 488 (1:1,500, Invitrogen) for 1 h at RT in the dark. After a final wash, the coverslips were mounted with Gelmount (Sigma) and sealed with clear nail polish. Imaging was performed with structured illumination (Zeiss Apotome Imager Z1) with a ϫ63 oil-immersion objective lens at wavelengths specific for the Alexa 488 fluorescent protein tag.
Enzyme-linked immunosorbent assay. mHCN2 constructs were tagged with an HA epitope in the extracellular S3-S4 loop and transfected into CHO cells as described above. Cells were incubated with mouse anti-HA antibody (1:1,000, Sigma) for 1 h at RT, followed by a goat anti-mouse HRP-conjugated secondary antibody (1:1,000, Santa Cruz) for 1 h at RT. Cells were then incubated with a chemiluminescent HRP substrate, and luminescence values at 425 nm were quantified on a PerkinElmer Victor 3 V plate reader. For measurements of total luminescence, cells were permeabilized with 0.2% Triton X-100. Background and untransfected luminescence values were subtracted for statistical comparisons using Student's t-tests between constructs. Data are reported as means Ϯ SE.
Electrophysiology and data analysis. For two-electrode voltageclamp recordings, cRNA was synthesized with a mMessage mMachine T7 kit (Ambion). RNA concentrations were determined with spectrophotometry and gel electrophoresis. Mature Xenopus laevis oocytes were injected with 5-25 ng of RNA and maintained in Barth's solution for 24 h before recording. Recording solution contained (in mM) 93 NaCl, 5 KCl, 2 MgCl 2, and 10 HEPES (pH 7.4, NaOH). For whole cell patch-clamp recordings, CHO cells maintained on coverslips were cotransfected with 0.7 g of pCDNA3-enhanced GFP (EGFP) and 2 g of the indicated constructs. Twenty-four to forty-eight hours after transfection, cells were transferred to a recording chamber and perfused with a low-K ϩ extracellular solution containing (in mM) 5.4 KCl, 135 NaCl, 0.5 MgCl2, 1.9 CaCl2, and 5 HEPES (pH 7.4, NaOH). After rupture of the patch membrane, this was switched to a high-K ϩ extracellular solution containing (in mM) 135 KCl, 5.4 NaCl, 0.5 MgCl 2, 1.9 CaCl2, and 5 HEPES (pH 7.4, KOH). Fully activated current protocols were carried out in the low-K ϩ extracellular solution. Briefly, prepulses to Ϫ150 mV were applied for 1 s, followed by pulses to test voltages ranging from Ϫ120 mV to ϩ30 mV. The pipette solution contained (in mM) 130 K-aspartate, 10 NaCl, 0.5 MgCl 2, 5 HEPES, and 1 EGTA (pH 7.4, KOH). Pipette resistances ranged from 2 to 4 M⍀. Sea urchin HCN channel (spIH) currents were recorded in low-K ϩ extracellular solution with saturating (2 mM) levels of cAMP added to the pipette solution. Voltage dependence of activation was determined from tail currents at Ϫ35 mV following test pulses of varying lengths of time in order to reach steady state; interpulse intervals were followed by a 100-ms pulse to ϩ5 mV to ensure complete channel deactivation. Resting current was always at baseline before subsequent voltage pulses. Normalized tail current amplitudes were plotted as a function of test potential and fitted with a Boltzmann function,
where V is potential and Imax is maximum current, to determine the midpoint of activation (V1/2) and slope factor (k). Activation at Ϫ150 mV was fitted with a double exponential; deactivation at Ϫ35 mV was fitted with a single exponential. Statistical comparisons were performed with Student's t-test or one-way ANOVA followed by Tukey's post hoc analysis. Data are reported as means Ϯ SE.
HCN sequence collection and analysis. With the exceptions of Ciona intestinalis sequences, all DNA sequences were retrieved from the ENSEMBL (v55), UCSC Genome Browser, JGI Genome Portal, and NCBI Entrez nonredundant nucleotide databases (8, 18, 20, 21) . Ciona sequences have been previously annotated (Ref. 19 ; see Supplemental Table S1 for detailed sequence information).
1 Translated protein sequences were aligned with MCoffee (50); these were then used to align the nucleotide sequences by codon. COOH-and NH 2-terminal regions were subsequently removed from the aligned nucleotide sequences, leaving the S1 through the cyclic nucleotide binding domain (cNBD) region. Predicted extracellular domains, based on annotations in the UniProt database (47a), were individually scanned for the Asn-X-Ser/Thr motif, in which X can be any amino acid except Pro. All figures were prepared with Adobe Illustrator CS3.
RESULTS

HCN2 channels undergo N-glycosylation in native cardiac
tissue. Both HCN1 and HCN2 are predominantly N-glycosylated in brain tissue (31, 39, 58) , but whether these channels are N-glycosylated in cardiac tissue is unknown. HCN1 and HCN2 are expressed in conduction tissue of the adult heart (28 -30, 43) and are found in various regions of embryonic and neonatal hearts (45, 56) and in cardiac embryonic stem cells (36, 40, 41, 55) . Studies from our lab (36, 53) and others (16, 24, 26, 45, 56) have shown that HCN2 contributes to the generation and modulation of heart rate in the embryonic stage, and knockout of HCN2 leads to significant reductions in hyperpolarizationactivated current (I h ) amplitudes recorded from individual embryonic cardiac myocytes (26) . Therefore, we probed whole heart lysates from E18 rats with an antibody directed to an NH 2 -terminal epitope and examined N-glycosylation by treating lysates with PNGase F, an enzyme that cleaves all N-linked glycans. Figure 1C shows a single band corresponding to HCN2 near 100 kDa. In the presence of PNGaseF, the HCN2 band is completely shifted to ϳ90 kDa, suggesting that cardiac HCN2 channels are fully N-glycosylated in vivo. These molecular masses are consistent with a nonproteolyzed form of HCN2, as has been reported for rat and human ventricles (17, 36, 46, 57, 59) .
To compare N-glycosylation of HCN2 in heart with that of heterologously expressed HCN2, we transfected mouse (m)HCN2 into CHO cells and performed Western blots as was done with heart lysates. We also expressed a mHCN2 channel in which the predicted Asn was substituted by Gln, for direct comparison with wild-type mHCN2 in the presence or absence of PNGaseF (Fig. 1D) . Western blots of CHO cell extracts expressing wild-type mHCN2 reveal two distinct molecular forms of the channel: a PNGaseF-insensitive band near 105 kDa, likely corresponding to immature, nonglycosylated channels, and a PNGaseF-sensitive band near 125 kDa, indicating N-glycosylated channels (Fig. 1D) . Notably, the shift in molecular mass of the upper band following PNGaseF treatment (ϳ20 kDa) was larger than that observed in heart lysates (ϳ10 kDa), possibly reflecting a higher level of complexity and/or difference in structure of the N-glycans attached to the channel when heterologously expressed in CHO cells. This difference was not unexpected, as the N-glycosylation of recombinant proteins in mammalian cell systems is highly sensitive to culture conditions and often varies between cell lines (3). As shown previously in HEK cells, mHCN2-N380Q is not sensitive to PNGaseF and is comparable in mass to the PNGaseFtreated wild-type mHCN2. Although we sometimes noted an apparent reduction in mHCN2-N380Q band intensity, this was not a consistent finding among all blots.
N-glycosylation is required for mHCN2 function in multiple expression systems. No Kv isoforms examined to date require N-glycosylation to fold correctly and form functional channels (4, 5, 7, 9, 13, 23, 31, 32, 34, 37, 38, 48, 51, 52, 54) . In contrast, mHCN2-N380Q reportedly fails to produce I h when transfected in HEK-293 cells (31) . Nevertheless, N-glycosylation mutants of other channels are sometimes functional only in certain cell lines or expression systems. Therefore, we expressed mHCN2-N380Q alongside the wild-type channel in Xenopus oocytes. This system was chosen for two reasons: first, nonglycosylated Shaker, the prototypical channel in the Kv superfamily, traffics to the plasma membrane much more efficiently in oocytes than in HEK cells (5, 38) . Second, certain HCN2 trafficking mutants that do not express functionally in mammalian cells (33, 35) do so in oocytes (49) . For comparison, we also expressed mHCN2-N380Q or wild-type mHCN2 in CHO cells.
Although wild-type mHCN2 produced robust I h (ϳ3-6 A) after injections of 5 ng RNA, we consistently found no detectable levels of this current for mHCN2-N380Q over several individual rounds of RNA synthesis using injections of 5-25 ng (Fig. 2A) . Severe reductions in current were also found in recordings from CHO cells (Fig. 2B) . Western blots of oocyte membrane extracts (Fig. 2C) show that mHCN2-N380Q protein is synthesized, but, as in CHO cells, the level was sometimes reduced compared with wild-type mHCN2. These blots also show that membrane-associated wild-type mHCN2 is sensitive to PNGaseF, yielding a band at the same position as mHCN2-N380Q, as was expected. The shift in molecular mass conferred by the absence of N-glycosylation in oocytes was more subtle than in hearts or CHO cells, again suggesting differences in the composition and/or size of the N-glycans among expression systems. Taken together, these data strongly suggest that N-glycosylation promotes the functional expression of mHCN2, either by enhancing function or by increasing the number of channels at the cell surface.
N-glycosylation promotes mHCN2 cell surface expression. An outstanding question arising from the above results, and from previous work in HEK cells (31) , is whether the increase in mHCN2 functional expression by N-glycosylation is due to an enhancement of function or to an increase in the cell surface expression of channel protein. To answer this question, we performed immunolabeling and imaging experiments to com-pare surface and total protein distribution of wild-type mHCN2 and mHCN2-N380Q. The channels were tagged with an HA epitope in the extracellular S3-S4 loop and expressed in CHO cells in the presence or absence of Triton X-100 to permeabilize cells. In the absence of Triton X-100, only channels localized to the cell surface could be visualized. In these nonpermeabilized cells (Fig. 3A, top) , an antibody to the HA tag reveals that wild-type mHCN2 is strongly expressed at the cell surface, whereas mHCN2-N380Q is only minimally present. In permeabilized cells (Fig. 3A, bottom) , wild-type mHCN2 and mHCN2-N380Q were visible throughout the cytoplasm as evenly spread puncta. This pattern of intracellular protein distribution was not notably different between CHO cells expressing wild-type mHCN2 and mHCN2-N380Q.
To confirm that the reduction in cell surface expression of mHCN2-N380Q was due to disruption of N-glycosylation and not a result of a sensitivity of the region to the Gln substitution, we created additional constructs individually substituting each residue in the Asn-X-Ser sequon to Ala, generating mHCN2-N380A, mHCN2-H381A, and mHCN2-S382A. Previous studies with the rabies virus glycoprotein have shown that N-glycan attachment is sensitive to single Ala substitutions in the Asn and Ser/Thr residues of the sequon, but that the efficiency of N-glycosylation is close to maximal when X is either His or Ala (22, 42) . Therefore, we expected that mHCN2-N380A and mHCN2-S382A, like mHCN2-N380Q, would have limited N-glycosylation and cell surface expression, whereas mHCN2-H381A would present a pattern not unlike the wild-type channel. These expectations were confirmed with Western blotting and immunolabeling combined with imaging to examine Nglycosylation and cell surface expression (Fig. 3, A and E) .
Effect of N-glycosylation on cell surface expression correlates only partly with an increase in total protein. To confirm and quantify the effect of N-glycosylation on cell surface mHCN2 and compare this with changes in total protein, we used a modified enzyme-linked immunosorbent assay (ELISA) to detect HA-tagged channels on the plasma membrane of transfected CHO cells. Figure 3B , left, shows that the surface expression of mHCN2-N380Q is significantly decreased compared with wild-type mHCN2. Consistent with the importance of Asn and Ser residues for N-glycosylation efficiency, cell surface expression is low, but not abolished, for both mHCN2- N380A and mHCN2-S382A (Fig. 3B, left) and comparable to that of an NH 2 -terminal-truncated mHCN2 (⌬NT) that poorly localizes to the cell surface (33, 47) . As predicted, mHCN2-H381A surface expression was not reduced, and was in fact significantly greater than that of wild-type mHCN2 (Fig. 3B,  left) .
Differences in protein expression among mHCN2 constructs were also observed in ELISA measurements of total protein in C1070 permeabilized cells (Fig. 3B, center) . Compared with wild-type mHCN2, total protein was significantly decreased for all nonglycosylated mutants and increased for mHCN2-H381A. To determine whether differences in total protein levels can account for the changes observed at the cell surface, we calculated the ratio of surface to total luminescence values for each construct (Fig. 3B, right) . Compared with wild-type mHCN2, the surface fraction of nonglycosylated mutants was reduced by ϳ50%, indicating that overall decreases in protein levels cannot fully explain the lower number of channels at the cell surface. In contrast, the surface fraction of mHCN2-H381A was similar to wild-type mHCN2, suggesting that the increased surface expression of this mutant corresponds to an overall increase in protein.
HCN2 channels lacking N-glycosylation form functional channels. An important and broad conclusion made in a previous study of mHCN2 in HEK cells was that N-glycosylation is required to obtain functional HCN channels (31) . However, in our ELISA experiments, we noted that cell surface expression of mHCN2 was not eliminated by disruption of Nglycosylation in CHO cells. To determine whether the surfacelocalized mutant channels were functional, we performed whole cell patch-clamp experiments in CHO cells (Fig. 3C) . The cells transfected with mHCN2-N380A, mHCN2-S382A, or mHCN2-N380Q were very fragile, and most often could not be reliably hyperpolarized beyond Ϫ100 mV. In cells expressing these channels, I h was never detectable at voltages less negative than Ϫ100 mV (data not shown). However, in a small number of cells, hyperpolarizing pulses to voltages more negative than Ϫ100 mV were tolerated and gave rise to a current with clear features of I h . Because such a slowly activating inward current in response to hyperpolarization of the membrane potential was never observed in untransfected or mock-transfected CHO cells, we are confident that it comes from the mutant mHCN2 subunits. The low level of current expression and the fragility of transfected cells precluded a more comprehensive functional analysis; therefore, it is not clear whether the lack of N-glycosylation affects channel function. Nevertheless, the identification of a distinct I h , even if only in a small number of cells, is still convincing evidence that N-glycosylation is not required for correctly folded and functioning mHCN2 channels. A strong influence of N-glycosylation on cell surface expression, as shown in Fig. 3A , is the best explanation for the corresponding decrease in current density found here and previously (31) .
In contrast, the current density of mHCN2-H381A was significantly larger than that of wild-type mHCN2 (Fig. 3, C  and D) , consistent with the greater overall cell surface expression observed for this mutant in ELISA experiments. The voltage dependence of activation did not noticeably differ between this mutant and the wild type: half-activation values were Ϫ113.0 Ϯ 4.9 mV (n ϭ 3) and Ϫ113.3 Ϯ 10 mV (n ϭ 3) for mHCN2-WT and mHCN2-H381A, respectively, implying no change in function. These data again suggest that the reduction in cell surface expression is due to disruption of N-glycosylation and not a consequence of mutation of the sequon.
N-glycosylation of HCN channels emerged in an ancestor common to chordates to promote cell surface expression. To date, a functional analysis of putative N-glycosylation has been carried out only with mHCN2, but all four mammalian isoforms contain the pore-associated sequon. Are they all as dependent on N-glycosylation of this sequon for cell surface expression? Evidence of HCN evolution suggests that they are not. We have previously shown (19) that, unlike most chordate and urochordate HCN sequences, known invertebrate sequences do not have the pore-associated sequon. Yet the invertebrate channels that have been cloned, which include those from Drosophila melanogaster, Apis mellifera, Panulirus argus, and Strongylocentrotus purpuratus (spIH), all produce I h in HEK cells (10 -12, 44) . Together these data suggest that an ancestor common to all chordates first acquired the pore-associated sequon but that glycosylation at this site was not required for cell surface expression. Therefore, we might expect that one or more vertebrate HCN isoforms that arose from this common ancestor also do not require N-glycosylation of this sequon for efficient cell surface expression.
A weakness of our previous analysis is that it was based on a limited representation of major groups of organisms. Fortunately, the sequencing of genomes is continuing at an accelerated rate, with many new HCN sequences becoming available from a much broader range of major invertebrate and vertebrate lineages. To more stringently test our hypothesis that the pore-associated sequon arose just prior to the chordate/urochordate lineage, we took advantage of the newly available sequences and performed a more extensive analysis in which the representation of major metazoan groups has been expanded. Importantly, cnidarian, mollusk, and annelid sequences have been added to our list of invertebrate sequences, while additional amphibian, fish, and mammalian sequences absent from the original analysis have now also been analyzed (19) . Supplemental Figure S1 shows a representative alignment of the S5 to pore region of 61 metazoan HCN sequences. Only chordate and urochordate HCN sequences contain the pore-associated sequon. These findings, summarized in Fig. 4 , strongly support our hypothesis that N-glycosylation at this site is not needed for surface localization of invertebrate HCN channels (10 -12, 44) .
Although invertebrate HCN sequences do not possess the pore-associated Asn-X-Ser/Thr sequon, none has been explicitly tested for N-glycan addition. To confirm that an invertebrate HCN isoform is both nonglycosylated and functional in Fig. 3 . N-glycosylation promotes mHCN2 cell surface expression. A: images showing immunolocalization of mHCN2 constructs in CHO cells. Channels were hemagglutinin (HA) tagged at the extracellular S3-S4 loop and fluorescently labeled in the presence or absence of Triton X-100 (TX-100) to permeabilize cells. Nonglycosylated channels do not reach the plasma membrane but are distributed similarly to mHCN2-WT in the cytoplasm of permeabilized cells. Exposure time was kept constant among all constructs for each condition. B, left and center: surface expression and total expression, respectively, of HA-tagged mHCN2 constructs in CHO cells. Cells expressing mHCN2 channels with disrupted N-glycosylation have greatly reduced luminescence compared with those expressing mHCN2-WT; n ϭ 4. Right: ratio of surface to total luminescence for cells expressing each construct. *P Ͻ 0.05. C: representative HCN-mediated current (Ih) traces (leak subtracted) recorded from CHO cells expressing WT and mutant mHCN2 channels. Note the difference in scale for mHCN2-S382A. D: comparison of Ih density of mHCN2-WT with mHCN2-H381A in CHO cells. *P ϭ 0.017. Ih density for mHCN2-N380Q, mHCN2-N380A, and mHCN2-S382A was most often negligible. Numbers of cells are indicated above each bar. E: Western blot of mHCN2 constructs expressed in CHO cells. Note the increased mature band for mHCN2-H381A compared with that of mHCN2-WT. Similar results were observed for at least 3 separate transfections.
our system, we expressed the sea urchin HCN channel (spIH) in CHO cells. Western blot analysis of spIH-transfected CHO cells reveals a PNGaseF-insensitive band at ϳ110 kDa, confirming that spIH is not N-glycosylated (Fig. 4B) . Nevertheless, this channel produces robust currents (Fig. 4C) , as it does in HEK cells (10, 44) , indicating that N-glycosylation is not required for surface localization of functional channels.
N-glycosylation is not required for efficient mHCN1 cell surface expression and function. Because spIH and other invertebrate channels form functional channels at the plasma membrane, it seems plausible that an ancestor common to both invertebrate and mammalian channels, but lacking the poreassociated sequon, was also able to do so. This line of reasoning led us to begin examining other mammalian HCN isoforms, with the idea that one of them may have retained the ability to traffic and function without N-glycan addition. To this end, we tested the mHCN1 isoform, which undergoes N-glycosylation in the brain (31, 39, 58) . Reprobing the E18 rat heart extracts ( Fig. 1C) for HCN1 with a COOH-terminal antibody shows that it is also present predominantly as a ϳ100-kDa N-glycosylated protein in embryonic cardiac tissue (Fig. 5A) . To verify that mHCN1 is N-glycosylated at the predicted sequon, we mutated the conserved Asn to Gln. Western blots of CHO cell extracts expressing wild-type mHCN1 reveal two bands, at ϳ110 kDa and 120 kDa, whereas mHCN1-N327Q produced only a single band near 110 kDa (Fig. 5B) .
In addition to being insensitive to PNGaseF and comparable in mass to the lower band of the PNGaseF-treated wild-type channel, the mHCN1-N327Q bands are less dense overall (Fig.  5B ), suggesting that, as was observed for nonglycosylated mHCN2 mutant channels, the total protein level is reduced. N-glycosylation at N327 in wild-type mHCN1 is strongly supported by these data. In stark contrast to nonglycosylated mHCN2 mutants, expression of mHCN1-N327Q in CHO cells results in robust I h ; current density is reduced by only 50% relative to wild-type mHCN1 (Fig. 5, C and D) . Moreover, cells expressing mHCN1-N327Q did not exhibit the fragility caused by nonglycosylated mHCN2 mutants. Together, these data strongly suggest isoform-specific sensitivity to N-glycosylation in the localization of mHCN1 and mHCN2 to the cell surface, in which the expression of mHCN1 is less tightly coupled to N-glycosylation than mHCN2.
Because the conserved N-glycosylation site is located in the outer portion of the pore and very near the selectivity filter in mammalian HCN channels, N-glycosylation could directly affect channel function. However, a comparison of reversal potential between mHCN1-N327Q and wild-type mHCN1 using physiological ionic concentrations shows no significant difference (Fig. 6A) , suggesting that selectivity and permeation are not altered by N-glycosylation despite the proximity of the sequon to the outer pore. We also found that the V 1/2 of I h activation is not significantly different between wild-type mHCN1 and mHCN1-N327Q (Fig. 6B) , although a small, but significant, difference in slope was observed (Fig. 6C) . Thus the decrease in I h density produced by the N327Q mutation, determined at Ϫ150 mV, is not due to a negative shift in the activation curve and a corresponding reduction of channel availability at that voltage. Moreover, analysis of channel kinetics reveals that the rates of slow and fast channel activation, as well as that of deactivation, are all unaffected in mHCN1-N327Q (Fig. 6D) . Because N327Q abolishes N-glycosylation completely (Fig. 5) , these findings suggest that N-glycan addition does not greatly affect mHCN1 function.
DISCUSSION
Previous studies have suggested that N-glycosylation is required for HCN channel function based only on experiments using the mHCN2 isoform. However, the absence of N-glycosylation in invertebrate isoforms, together with their ability to form functional channels in mammalian cells, suggested to us that the influence of N-glycosylation might have evolved in a variable manner among vertebrates such that, after gene duplication, not all of the resulting HCN isoforms became as heavily dependent on N-glycosylation for function. This was confirmed here, where we show that both mHCN1 and mHCN2 are N-glycosylated at a site between S5 and the pore and that, surprisingly, neither requires this posttranslational modification for function. Notably, we do find that mHCN1, unlike mHCN2, is robustly expressed at the plasma membrane without N-glycan addition. These findings are consistent with an evolutionary trajectory whereby a HCN common ancestor acquired the S5 pore N-glycosylation site and vertebrate isoforms later accumulated amino acid changes that variably altered dependence on N-glycosylation for cell surface expression. Hence, mHCN2 may have become more reliant on N-glycans for surface expression over the course of evolution, whereas mHCN1 remained less so.
Although we show that cell surface expression of mHCN2 is more dependent on N-glycosylation than mHCN1, the molecular basis underlying this dependence and the difference between the isoforms remains to be established. Our data suggest that factors independent of total protein levels contribute to the maintenance of cell surface expression. In general, N-glycosylation yields glycoproteins that are recognized by ER chaperones during folding. Once the native conformation is attained, the glycoprotein is released and proceeds to the Golgi; misfolded proteins are retained in the ER and may be targeted for degradation (2, 14) . Future experiments will examine the role of N-glycosylation on the interaction of HCN channels with chaperones and their relative stability in the cell, and will identify the regions that are responsible for the differences among HCN isoforms.
A novel finding in this study was the apparent lack of strong effects of N-glycosylation on mHCN1 channel function. Despite the proximity of the sequon to the selectivity filter and outer pore, the N327Q mutation had no discernible effects on mHCN1 I h activation and deactivation kinetics, or on selectivity and permeation (Fig. 6) . Likewise, the position of the I h activation curve does not change, although the slope is somewhat steepened. Thus our data suggest that N-glycosylation only minimally impacts mHCN1 function.
We found both HCN1 and HCN2 in embryonic cardiac tissue in significant amounts, consistent with previous reports. Both isoforms are present in predominantly N-glycosylated and nonproteolyzed forms, although the nature of N-glycan attachment may be different from that found in other cell types such as CHO cells. Together, our data suggest that cell surface expression of HCN1 in native tissue may also be less dependent on the extent of N-glycosylation compared with HCN2. It will be important to determine how tightly expression of the various HCN isoforms is coupled to N-glycosylation in vivo, and whether this coupling is regulated to affect excitability in cardiac myocytes and neurons.
